ACTIVE CITIZENSHIP NETWORK
Menu

Projects

Why prevention now: the policy & economic rationale

Antimicrobial resistance (AMR) is one of the defining public health challenges of our time, requiring a structural shift from a purely reactive model—focused solely on treatment—to a prevention-first, people-centered strategy.

Prevention has broad political support and weak financial protection. Governments endorse it in declarations and strategies, yet prevention budgets are often the first to be reduced when health spending is under pressure.

  • The Funding Gap: Across OECD countries, prevention accounted for just 3% of total health spending in 2023. The share rose to around 6% during the COVID-19 pandemic, then fell back to its earlier level (OECD, Health at a Glance 2025).
  • The Human Burden: According to ECDC estimates, antimicrobial-resistant infections claim around 35,000 lives each year in the EU/EEA, with Italy carrying one of the heaviest burdens in Europe (approx. 12,000 deaths annually).

The current discussions on sustainable health financing and on the reform of the global health architecture create a crucial opening to change how prevention is valued and funded.

Strategic vision & long-term roadmap

Following the side-event roundtable - — also co-promoted by Active Citizenship Network (ACN)—held in Geneva (Switzerland) titled “Preventing Antimicrobial Resistance: Stewardship, Education, and Diagnostics” on the sidelines of the Seventy-ninth World Health Assembly, the project “Advancing infection prevention to tackle AMR in Europe” reaffirms Cittadinanzattiva–Active Citizenship Network’s long-term European commitment to tackling antimicrobial resistance.

Scheduled for the second half of 2026, the project’s core activities focus on a dedicated social media campaign (“Preventing Infections, Protecting People”, on the occasion of the World AMR Awareness Week 2026) alongside targeted awareness-raising initiatives.

Rather than a one-off initiative, this project serves as a strategic stepping stone toward the 2027 high-level institutional event on AMR at the European Parliament, to be hosted by Active Citizenship Network with the political support of the MEPs Interest Group “European Patients' Rights and Cross-border Healthcare”.

Our Global & European Institutional Commitment

Cittadinanzattiva, through its EU branch Active Citizenship Network, is a member of the AMR Multi-Stakeholder Partnership Platform (established and facilitated by the Quadripartite: FAO, UNEP, WHO, and WOAH) and the WHO Civil Society Task Force on Antimicrobial Resistance (AMR). In particular:

  • The AMR Multi-Stakeholder Partnership Platform, established and facilitated by the Quadripartite organizations (FAO, UNEP, WHO, and WOAH), aims to catalyse a global movement for action against antimicrobial resistance (AMR) by fostering cooperation between a diverse range of stakeholders at all levels across the One Health spectrum. It seeks to ensure a healthier, more sustainable, and resilient present and future in which antimicrobials are preserved as critical lifesaving medicines accessible to everyone. The Coordinating Team of the Platform is hosted by FAO.
  • The WHO Civil Society Task Force on AMR was launched to support and strengthen the World Health Organization’s engagement with non-governmental organisations, including civil society groups, worldwide. Its mission is to ensure that civil society groups are able to effectively contribute to the global fight against AMR, securing equitable access to prevention, treatment, and care for all, especially vulnerable populations.

Through its participation in these international initiatives, ACN brings the perspective of citizens and patients to the global dialogue on antimicrobial resistance, advocating for prevention-oriented policies, meaningful civic engagement, and stronger collaboration among stakeholders.

Preventing AMR requires collective action: citizens and patients must be part of the solution.

Read more about our policy on patient safety: focus on Healthcare-Associated Infections (HAIs) and Antimicrobial Resistance (AMR)

To know more, please contact us at: This email address is being protected from spambots. You need JavaScript enabled to view it.

The project is realized thanks to the unconditional support of

  • om pharma

Last updated: November 2026

Subscribe to the newsletter

Valore non valido

Valore non valido

Valore non valido


Valore non valido

Valore non valido